Search results
Found 30878 matches for
New research from Dr Richard Williams’ group at the Kennedy Institute suggests a route for the development of more selective – and effective – therapies for immune-mediated inflammatory disease.
Clinical Kennedy Trust Prize Studentships
Applications for these projects are now closed. Please visit the website in summer 2026 to see available projects for October 2027 entry.
Botnar projects
Applications for these projects are now closed. Please visit the website in summer 2026 to see available projects for October 2027 entry.
Themes
OCTRU runs trials across multiple areas of medicine. Within OCTRU there are five core therapeutic areas of expertise, although trials are also undertaken outside of these areas and groups.
Meet the team
-
I-Shu Huang
Postdoctoral Researcher
-
Felix Clanchy
Senior Postdoctoral Researcher
-
Sir Marc Feldmann FRS
Emeritus Professor
-
Richard Williams
Professor
TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells